Zevin Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Zevin Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-97,690	Closed	-$1.73M	–	125
2016 Q4	$1.73M	Sell	97,690 -23,640	-19%	-$415K	0.45%	49
2016 Q3	$2.34M	Sell	121,330 -3,225	-3%	-$63.1K	0.75%	37
2016 Q2	$2.43M	Buy	124,555 +4,230	+4%	+$83K	0.67%	41
2016 Q1	$2.48M	Buy	120,325 +1,260	+1%	+$24.8K	0.7%	41
2015 Q4	$2.44M	Buy	119,065 +18,180	+18%	+$349K	0.64%	44
2015 Q3	$1.73M	Buy	100,885 +1,175	+1%	+$21.5K	0.5%	55
2015 Q2	$1.86M	Buy	99,710 +830	+0.8%	+$15.4K	0.5%	59
2015 Q1	$1.89M	Sell	98,880 -5,660	-5%	-$105K	0.52%	59
2014 Q4	$1.72M	Buy	104,540 +2,135	+2%	+$36.6K	0.48%	66
2014 Q3	$1.81M	Buy	+102,405	New	+$2.01M	0.53%	61

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Zevin Asset Management's VIVO Position: Q1 2017 in Review

Zevin Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 97,690 shares — an estimated $1.73M sold.

Zevin Asset Management first reported a position in VIVO in Q3 2014 and held it in 10 quarters. The position peaked at $2.48M in Q1 2016. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

Zevin Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
Zevin Asset Management sold 97,690 Meridian Bioscience Inc shares in Q1 2017, an estimated $1.73M.
Zevin Asset Management first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 10 quarters.
Zevin Asset Management's Meridian Bioscience Inc position peaked at $2.48M in Q1 2016.
165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Zevin Asset Management's 13F filing for Q1 2017, filed 5 May 2017.